Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nine Pivotal Studies To Look Out For In 2024

Feb 05 2024

• By Alexandra Shimmings

formula

Related Content

AbbVie Strikes Again By Teeing Up $8.7bn Offer For Cerevel

Dec 06 2023

Lack Of Efficacy, Not Safety, Dooms Merck KGaA’s BTK Inhibitor

Dec 06 2023

Blow To Roche Growth Prospects As TIGIT Lung Cancer Trial Fails

May 11 2022

Sanofi Matches, But Does Not Better, Amgen In OX40 Contest

Oct 17 2023

Related Companies

Sanofi

GSK plc

Amgen, Inc.

Glenmark Pharmaceuticals Limited

Ichnos Glenmark Innovation

ImageneBio, Inc.

Cerevel Therapeutics Holdings, Inc.

Karuna Therapeutics, Inc.

Bristol Myers Squibb Company

Johnson & Johnson

Neumora Therapeutics, Inc.

Merck & Co., Inc.

Roche Holding AG

CRISPR Therapeutics AG

Vertex Pharmaceuticals Incorporated

Novo Nordisk A/S

Eli Lilly and Company

Additional Topics

Clinical Trials Commercial Innovation Research & Development Cancer Dermatology Immune Disorders Metabolic Disorders Neurology Respiratory BioPharmaceutical

More from Innovation

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window